DEPO-TESTADIOL (estradiol cypionate; testosterone cypionate) by Pfizer is clinical pharmacology endogenous estrogens are largely responsible for the development and maintenance of the female reproductive system and secondary sexual characteristics. Approved for the treatment of: 1. First approved in 1980.
Drug data last refreshed 34m ago · AI intelligence enriched 1w ago
DEPO-TESTADIOL is a fixed-dose combination injectable containing estradiol cypionate and testosterone cypionate, designed for hormone replacement therapy. It works by binding to nuclear estrogen receptors to maintain reproductive system function and secondary sexual characteristics, with effects mediated through modulation of gonadotropin (LH/FSH) secretion. The product is administered via intramuscular injection with prolonged absorption over several weeks.
Product is in late-stage maturity with LOE approaching; career opportunities likely concentrated in defensive strategies and transition planning rather than growth initiatives.
CLINICAL PHARMACOLOGY Endogenous estrogens are largely responsible for the development and maintenance of the female reproductive system and secondary sexual characteristics. Although circulating estrogens exist in a dynamic equilibrium of metabolic interconversions, estradiol is the principal…
Worked on DEPO-TESTADIOL at Pfizer? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/moWorking on DEPO-TESTADIOL offers limited career growth potential due to its LOE-approaching lifecycle and minimal linked job openings (0 identified). This role is most suitable for professionals seeking to develop expertise in lifecycle management, generic defense strategies, and maintaining market presence in mature products rather than driving innovation or market expansion.